PL2268603T3 - Proces wytwarzania 2-amino-2-[2-(4-C3-C21-alkilo-fenylo)etylo]propano-1,3-dioli - Google Patents

Proces wytwarzania 2-amino-2-[2-(4-C3-C21-alkilo-fenylo)etylo]propano-1,3-dioli

Info

Publication number
PL2268603T3
PL2268603T3 PL09721774T PL09721774T PL2268603T3 PL 2268603 T3 PL2268603 T3 PL 2268603T3 PL 09721774 T PL09721774 T PL 09721774T PL 09721774 T PL09721774 T PL 09721774T PL 2268603 T3 PL2268603 T3 PL 2268603T3
Authority
PL
Poland
Prior art keywords
diols
propane
phenyl
ethyl
amino
Prior art date
Application number
PL09721774T
Other languages
English (en)
Inventor
Gottfried Sedelmeier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2268603T3 publication Critical patent/PL2268603T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL09721774T 2008-03-19 2009-03-17 Proces wytwarzania 2-amino-2-[2-(4-C3-C21-alkilo-fenylo)etylo]propano-1,3-dioli PL2268603T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08153033 2008-03-19
PCT/EP2009/053163 WO2009115534A1 (en) 2008-03-19 2009-03-17 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl] propane-1, 3-diols
EP20090721774 EP2268603B1 (en) 2008-03-19 2009-03-17 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl]propane-1, 3-diols

Publications (1)

Publication Number Publication Date
PL2268603T3 true PL2268603T3 (pl) 2015-07-31

Family

ID=40848446

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09721774T PL2268603T3 (pl) 2008-03-19 2009-03-17 Proces wytwarzania 2-amino-2-[2-(4-C3-C21-alkilo-fenylo)etylo]propano-1,3-dioli

Country Status (17)

Country Link
US (2) US8809571B2 (pl)
EP (1) EP2268603B1 (pl)
JP (2) JP5698118B2 (pl)
KR (1) KR101641742B1 (pl)
CN (1) CN101959845A (pl)
AR (1) AR072776A1 (pl)
AU (1) AU2009226975B2 (pl)
BR (1) BRPI0908727A2 (pl)
CA (1) CA2717934C (pl)
ES (1) ES2536552T3 (pl)
IL (1) IL208019A (pl)
MX (1) MX2010009931A (pl)
PL (1) PL2268603T3 (pl)
PT (1) PT2268603E (pl)
RU (1) RU2529474C2 (pl)
WO (1) WO2009115534A1 (pl)
ZA (1) ZA201006058B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809571B2 (en) * 2008-03-19 2014-08-19 Novartis Ag Process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
EP2896609B1 (en) * 2009-07-24 2018-06-27 ratiopharm GmbH Crystalline fingolimod citrate for the treatment of relapsing-remitting multiple sclerosis
WO2012071524A1 (en) 2010-11-24 2012-05-31 Ratiopharm Gmbh Arylsulfonate salts of fingolimod and processes for preparation thereof
WO2012146980A2 (en) 2011-04-29 2012-11-01 Dr. Reddy's Laboratories Ltd. Preparation of fingolimod and its salts
CZ2012406A3 (cs) 2012-06-15 2013-12-27 Zentiva, K.S. Způsob výroby fingolimodu založený na otevírání aziridinového kruhu
JP7078190B1 (ja) 2022-01-31 2022-05-31 トヨタ自動車株式会社 保持部材、射出装置、及び差し込み方向ガイド方法
JP7268779B1 (ja) 2022-01-31 2023-05-08 トヨタ自動車株式会社 保持部材

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0627406T3 (da) 1992-10-21 1999-07-12 Taito Co 2-Amino-1,3-propandiolforbindelser og immunundertrykkende midler
IT1265101B1 (it) * 1993-07-23 1996-10-30 Erba Carlo Spa Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ES2237970T3 (es) * 1998-11-11 2005-08-01 Novartis Ag Produccion de 2-amino-2-(2-(4-alquil c2-20-fenil)etil)propano-1,3-dioles.
CN1144779C (zh) * 1999-03-11 2004-04-07 杭州中美华东制药有限公司 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物
CN1169768C (zh) * 2002-04-26 2004-10-06 中国科学院上海有机化学研究所 （4－炔基）－芳香酮酸类化合物、合成方法及应用
JP3972021B2 (ja) 2003-05-28 2007-09-05 東京応化工業株式会社 プラズマディスプレイ前面板製造用未焼成積層体およびプラズマディスプレイ前面板の製造方法
AU2006214314B2 (en) * 2005-02-14 2012-02-09 University Of Virginia Patent Foundation Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups
TW200702326A (en) 2005-05-31 2007-01-16 Mitsubishi Pharma Corp 2-aminobutanol compound and its pharmaceutical use
US8809571B2 (en) * 2008-03-19 2014-08-19 Novartis Ag Process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein

Also Published As

Publication number Publication date
CN101959845A (zh) 2011-01-26
IL208019A0 (en) 2010-12-30
CA2717934C (en) 2017-07-18
RU2010142397A (ru) 2012-04-27
IL208019A (en) 2015-10-29
AR072776A1 (es) 2010-09-22
ZA201006058B (en) 2011-05-25
BRPI0908727A2 (pt) 2015-07-28
JP2011515364A (ja) 2011-05-19
CA2717934A1 (en) 2009-09-24
US20140094625A1 (en) 2014-04-03
RU2529474C2 (ru) 2014-09-27
ES2536552T3 (es) 2015-05-26
EP2268603B1 (en) 2015-04-22
AU2009226975A1 (en) 2009-09-24
KR20100127279A (ko) 2010-12-03
JP2015028056A (ja) 2015-02-12
US8809571B2 (en) 2014-08-19
JP5955364B2 (ja) 2016-07-20
JP5698118B2 (ja) 2015-04-08
EP2268603A1 (en) 2011-01-05
MX2010009931A (es) 2010-09-30
KR101641742B1 (ko) 2016-07-21
US9133096B2 (en) 2015-09-15
US20110015425A1 (en) 2011-01-20
PT2268603E (pt) 2015-06-08
WO2009115534A1 (en) 2009-09-24
AU2009226975B2 (en) 2012-09-06

Similar Documents

Publication Publication Date Title
HK1210137A1 (en) Process for the preparation of 2,3,3,3-tetrafluoropropene 2333-
HK1153728A1 (zh) 製備 -四氟丙烯的方法
ZA201007526B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
EP2349962A4 (en) METHOD FOR PRODUCING HYDROCHLORO FLUOROLEFINES
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
ZA201006842B (en) Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
EP2262813A4 (en) IMPROVED PROCESS FOR THE PREPARATION OF MORPHINANE ANALOGS
IL203761A (en) Process for Preparation of Compounds 4 - Aminobut - 2 - Anabolic, Intermediate and Initial Compounds
SI2151428T1 (sl) Postopek za pripravo agomelatina
ZA201102424B (en) Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans
IL208019A (en) Process for Preparation of 2-Amino-2 - [2 - (4 - 3 c-21c - Alkyl-Phenyl) Ethyl] Propane-3,1-Diols
ZA200907191B (en) Process for the preparation of gefitiib
IL211556A0 (en) Process for the preparation of pramlintide
IL231141A (en) Process for making 2 - (6-fluoro-1 h-indole-3-yl) - n, n - dimethylmethanamine
PL2417086T3 (pl) Sposób wytwarzania 3,3,3-trifluoropropenu
AU2009254929A8 (en) An improved process for the preparation of amines
IL208514A0 (en) Process for preparing substituted biphenylanilides
SI2281801T1 (sl) Postopek za pridobivanje 3,3-diphenilpropilamina
IL207222A0 (en) Process for preparing hebivolol
SI2151429T1 (sl) Postopek za pripravo agomelatina
EG26332A (en) Process for the preparation of benzonoprons
ZA200907695B (en) Process for preparing dorzolam ide
EP2280938A4 (en) PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE
EP2197273A4 (en) PROCESS FOR THE PREPARATION OF R-GOSSYPOL L-PHENYLALANINOL DIENAMINE
IL211382A0 (en) Process for the preparation of ethanedinitrile